Section Arrow
AXNX.NASDAQ
- Axonics
Quotes are at least 15-min delayed:2024/05/15 18:20 EDT
Last
 67.69
+0.24 (+0.36%)
Day High 
67.75 
Prev. Close
67.45 
1-M High
67.91 
Volume 
229.73K 
Bid
67.65
Ask
70
Day Low
67.4 
Open
67.75 
1-M Low
66.32 
Market Cap 
3.44B 
Currency USD 
P/E -- 
%Yield
10-SMA 67.32 
20-SMA 67.05 
50-SMA 67.68 
52-W High 69.68 
52-W Low 47.59 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.31/0.45
Enterprise Value
3.47B
Balance Sheet
Book Value Per Share
12.29
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
366.38M
Operating Revenue Per Share
6.71
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SINTSiNtx Technologies0.1276+0.0726+132.00%-- 
CATXPerspective Therapeutics1.57-0.19-10.80%-- 
PACBPacific Biosciences of California2.145-0.085-3.81%-- 
ZOMZomedica Corp0.1692+0.0231+15.81%-- 
AEMDAethlon Medical0.4-0.4501-52.95%-- 
Quotes are at least 15-min delayed:2024/05/15 18:20 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.